Grave Clinicopathologic Correlation: A Case of Hyperthyroxinemia

Journal of Applied Laboratory Medicine

Volumn 1, Issue 3, 2016, Pages 310-314

  Mattman, Andre ^a   Demarco, Mari L ^a   Wong, Sophia ^a   Holmes, Daniel T ^a   Lee, Julie ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85016233731     PISSN: None     EISSN: 24757241     Source Type: Journal    
DOI: 10.1373/jalm.2016.020966     Document Type: Article

References (9)

1. Peltier L, Massart C, Moineau MP, Delhostal A, Roudaut N. Anti-streptavidin interferences in Roche thyroid immunoassays: a case report. Clin Chem Lab Med 2016; 54:e11-4.
2. Cartwright D, O'Shea P, Rajanayagam O, Agostini M, Barker P, Moran C, et al. Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin Chem 2009;55:1044-6.
3. Ryan JB, Brennan SO, Potter H, Wolmarans L, Florkowski CM, George PM. Familial dysalbuminaemic hyperthyroxinaemia: a rapid and novel mass spectrometry approach to diagnosis. Ann Clin Biochem 2016;53:504-7.
4. Ohba K, Noh JY, Unno T, Satoh T, Iwahara K, Matsushita A, et al. Falsely elevated thyroid hormone levels caused by anti-ruthenium interference in the Elecsys assay resembling the syndrome of inappropriate secretion of thyrotropin. Endocr J 2012;59:663-7.
5. Rulander NJ, Cardamone D, Senior M, Snyder PJ, Master SR. Interference From Anti-Streptavidin Antibody. Arch Pathol Laboratory Med 2013;137: 1141-6.
6. Buijs MM, Gorgels JP, Endert E. Interference by antiruthenium antibodies in the Roche thyroidstimulating hormone assay. Ann Clinical Biochem 2011; 48:276-81.
7. Zaninotto M, Tognon C, Venturini R, Betterle C, Plebani M. Interference in thyroid hormones with Roche immunoassays: an unfinished story. Clin Chem Lab Med 2014;52:e269-70.
8. Scheinfeld N, Dahdah MJ, Scher R. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol 2007;6:782-7.
9. Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D, et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 2015;31:159-69.